BTSC

 
Common Stock Alternative Reporting
Pink Current Information
Verified Company Profile 8/15/2017
Contact Info
  • 910 16th Street
  • Suite 412
  • Denver, CO 80202

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Not Available
Latest Report Jun 30, 2017 Quarterly Report
CIK 0001094735
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 9995 - Non-Operating Establishments
Incorporated In: CO, USA
Year of Inc. 2004
Employees 5 a/o Aug 14, 2017
Company Officers/Contacts
Joel Schneider CEO, CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel
Matheau J.W. Stout Esq.
400 E. Pratt St.
8th Floor
Baltimore, MD, 21202
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Tulip BioMed, Inc. until 3-2016
  • Formerly=Cell Bio-Systems, Inc. until 6-06
  • Formerly=Direct Music Group, Inc. until 4-04
  • Formerly=BMX Holdings Inc. until 2-03
  • Formerly=JLL Miami Enterprises, Inc. until 1-02
BTSC Security Details
Share Structure
Market Value1 $39,598,781 a/o Oct 16, 2017
Authorized Shares 1,890,000,010 a/o Aug 14, 2017
Outstanding Shares 639,721,827 a/o Aug 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 233,330,221 a/o Aug 14, 2017
Par Value 0.001
Transfer Agent(s)
Signature Stock Transfer, Inc.
Shareholders
Shareholders of Record 415 a/o Aug 14, 2017
Short Selling Data
Short Interest 547,656 (20.09%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security